Arthur Fratamico is Chief Business Officer at Vitae Pharmaceuticals, Inc (VTAE). They have made 1 open-market trade across 1 company since 2015, most recently 2021-05-25.
CIK 0001598129
1 open-market purchase totalling $78K since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VTAE | BUY | 2015-08-27 | 2015-08-31 | $7.83 | $78K | -36.0% | -1.4% | -1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.